**Robust IPO activity through September 2026, with 109 U.S. deals raising $146.5 billion year-to-date, reflects strong trader sentiment that several high-profile companies could list before year-end.** Mega-deals such as SpaceX’s June pricing at an $86 billion valuation have demonstrated market capacity for large AI and tech issuers, while broader participation in biotech, infrastructure, and consumer names supports continued momentum. Recent pricings, including Oura and Accelevation scheduled for late September, highlight a selective but open window, though concerns over elevated Treasury yields, potential Fed rate hikes, and AI spending scrutiny have tempered expectations for smaller or later-stage candidates. Macro stability, upcoming economic data releases, and aftermarket performance of recent listings will be key swing factors influencing whether additional unicorns clear regulatory and valuation hurdles by December 31.